Quick info
MDA, MDEA and MBDB are synthetic amphetamine derivatives and closely related to the better known MDMA. They belong to the group of empathogens.
MDA (3,4-methylenedioxyamphetamine, also 1-[1-3-benzodioxol-5-yl]-2-proponamine) is a synthetic amphetamine derivative; together with MDMA it is sometimes found in ecstasy pills, more rarely in pure form.
MDEA (3,4-methylenedioxyethylamphetamine) is a synthetic amphetamine derivative that is rarely found together with MDMA in ecstasy.
MBDB (N-methyl-1-2-butanamine) is a synthetic amphetamine derivative.
These three substances are closely related to MDMA. They differ from ecstasy and from each other mainly in how well one's own feelings are perceived (entactogenic effect), how strong empathic understanding (empathic effect) and hallucinogenic effects occur.
MDA 1.3 mg per kg body weight (1.3 mg x 80 kg = 100 mg)
MDEA 1.3 mg per kg body weight (1.3 mg x 80 kg = 100 mg)
MBDB 1.5 mg per kg body weight (1.5 mg x 80 kg = 120 mg)
Onset of action
MDA: after 30-45 minutes
MDEA: after 30-45 minutes
MBDB: after 30-60 minutes
Duration of action
MDA: 8 - 12 hours
MDEA: 4 - 6 hours
MBDB: 4 - 5 hours
Nausea to nausea, dry mouth, cramping of the jaw muscles, sweating, coordination disorders, sleep disorders and trembling.
Long-term risks
MDA is both neurotoxic (damaging to the nerves) and hepatotoxic (damaging to the liver), and regular use can lead to schizophrenia-like symptoms.
First test a third or half a pill.
Wait two hours for the effect to take effect before adding more.
With MDA, topping up is pointless, as it is effective for a long time even in small doses.
Refrain from mixed consumption.
Avoid alcohol, consume sufficient non-alcoholic beverages (3-5 dl per hour).
Take breaks from dancing at parties and get some fresh air in between.
Take regular breaks from consumption. The body needs time to recover.
People taking medication are advised to inform themselves about interactions.
LSD analogues are substances that are chemically very similar to LSD and can have comparable effects. Some of them have been known for a long time (e.g. ALD52, ETH-LAD, AL-LAD, PRO-LAD etc.) and have been studied pharmacologically as well as psychopharmacologically, at least in part. Others are newer "creations" (e.g. the derivatives 1P-LSD,1B-LSD, 1cP-LSD, 1V-LSDetc.), for which only few or no data are available. Certain LSD analogues can (still) be legally produced, traded and consumed in some countries, which is the main reason for their distribution.
Most LSD analogues are naturally different from LSD in their effect and/or potency (e.g. ETH-LAD, AL-LAD, LSZ etc.). In contrast, the so-called 1-acylated LSD compounds (e.g. 1P-LSD, 1V-LSD, 1B-LSD, ALD-52, etc.) are presumed, on the basis of pharmacological studies, to convert into LSD in the body (they function as so-called prodrugs) and thus have a comparable psychoactive effect to LSD.
In the case of prodrugs of LSD and LSD analogues, it has not been conclusively clarified whether, in addition to their psychoactive effect, they can produce other pharmacological effects. How potent these prodrugs are compared to the resulting substance (e.g., 1P-LSD to LSD), and to what extent a delay in onset of action occurs in each case, may be substance-dependent and cannot be generalized. Therefore, it is important to approach the dose/effect carefully to avoid overdoses.
If you or someone else needs urgent help after taking drugs or alcohol, call an ambulance on 144. Tell the emergency responders everything you know.
It could save lives.